Aperio Group’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.71M Sell
30,251
-4,886
-14% -$276K 0.01% 1315
2020
Q3
$1.67M Buy
35,137
+3,866
+12% +$183K 0.01% 1204
2020
Q2
$1.84M Buy
31,271
+3,741
+14% +$221K 0.01% 1151
2020
Q1
$1.3M Buy
27,530
+7,454
+37% +$352K 0.01% 1196
2019
Q4
$1.21M Sell
20,076
-2,459
-11% -$149K ﹤0.01% 1330
2019
Q3
$1.35M Buy
22,535
+612
+3% +$36.7K 0.01% 1236
2019
Q2
$1.41M Buy
21,923
+3,279
+18% +$211K 0.01% 1226
2019
Q1
$1.51M Buy
18,644
+2,864
+18% +$233K 0.01% 1166
2018
Q4
$853K Sell
15,780
-424
-3% -$22.9K ﹤0.01% 1398
2018
Q3
$836K Buy
16,204
+1,203
+8% +$62.1K ﹤0.01% 1509
2018
Q2
$625K Sell
15,001
-2,976
-17% -$124K ﹤0.01% 1643
2018
Q1
$792K Buy
17,977
+508
+3% +$22.4K ﹤0.01% 1454
2017
Q4
$879K Sell
17,469
-528
-3% -$26.6K ﹤0.01% 1382
2017
Q3
$912K Buy
17,997
+341
+2% +$17.3K 0.01% 1327
2017
Q2
$898K Buy
17,656
+574
+3% +$29.2K 0.01% 1292
2017
Q1
$687K Sell
17,082
-1,560
-8% -$62.7K ﹤0.01% 1364
2016
Q4
$892K Buy
18,642
+6,876
+58% +$329K 0.01% 1188
2016
Q3
$431K Buy
11,766
+1,479
+14% +$54.2K ﹤0.01% 1534
2016
Q2
$240K Buy
10,287
+2,982
+41% +$69.6K ﹤0.01% 1765
2016
Q1
$296K Sell
7,305
-9,516
-57% -$386K ﹤0.01% 1665
2015
Q4
$1.04M Buy
16,821
+8,667
+106% +$537K 0.01% 996
2015
Q3
$330K Buy
8,154
+3,789
+87% +$153K ﹤0.01% 1527
2015
Q2
$251K Buy
4,365
+614
+16% +$35.3K ﹤0.01% 1738
2015
Q1
$239K Buy
+3,751
New +$239K ﹤0.01% 1715